Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014–2019: a retrospective health claims analysis
In Germany, the clinical and economic burden of RSV is substantial, especially in the most vulnerable population, that is, very young infants, those born premature and/or those with an underlying disease.
Authors
- Tobias Tenenbaum (ORCID: https://orcid.org/0000-0002-7215-8398)
- Lea Bayer (ORCID: https://orcid.org/0000-0002-8516-0745)
- Jennifer Riedel (ORCID: https://orcid.org/0000-0001-7605-3449)
- Gordon Brestrich (ORCID: https://orcid.org/0000-0002-1306-5474)
- Bennet Huebbe
- S. N. Melnik
- Christof von Eiff (ORCID: https://orcid.org/0000-0002-7821-2359)
- Caroline Lade
Institutions
- Sana Klinikum Lichtenberg (DE)
- Pfizer (Germany) (DE)
- IGES Institut (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Infection
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1007/s15010-024-02391-x
- Citations
- 4
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.55
Funders
- Pfizer